Related Experiment Video
Updated: May 13, 2026
06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
E6AP/UBE3A ubiquitin ligase harbors two E2~ubiquitin binding sites
Virginia P Ronchi1, Jennifer M Klein, Arthur L Haas
1Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA.
The Journal of Biological Chemistry
|February 27, 2013
Summary
Researchers quantitatively examined the human E6AP/UBE3A enzyme mechanism, identifying UbcH7 as the key E2 carrier protein. They discovered a novel two-step mechanism for polyubiquitin chain formation, crucial for the degradation signal.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- The E3 ubiquitin ligase E6AP/UBE3A plays a critical role in protein degradation pathways.
- Understanding its enzymatic mechanism is essential for elucidating cellular processes and disease pathologies.
- Previous models of Hect domain-catalyzed conjugation lacked detailed mechanistic insights.
Purpose of the Study:
- To quantitatively characterize the enzymatic mechanism of human E6AP/UBE3A for the first time.
- To identify the cognate E2 carrier protein and elucidate the kinetics of polyubiquitin chain formation.
- To resolve the functional roles of different binding sites and residues in E6AP activity.
Main Methods:
- Utilized (125)I-polyubiquitin chain formation as a functional readout of enzyme activity.
- Performed initial rate studies to determine kinetic parameters (Km, kcat) with varying E2 concentrations.
- Employed competitive and noncompetitive inhibition assays using substrate and product analogs.
Main Results:
- Identified UbcH7 as the cognate E2 carrier protein for E6AP, with hyperbolic kinetics observed.
- Demonstrated substrate inhibition at high E2 concentrations, indicating multiple binding sites.
- Uncovered a novel two-step mechanism involving a cryptic Site 1 for thioester formation and canonical Site 2 for chain elongation.
- Showed that Phe(849) is critical for polyubiquitin chain formation, not target conjugation.
Conclusions:
- The human E6AP/UBE3A enzyme operates via a novel two-step mechanism, distinct from previous models.
- A cryptic binding site (Site 1) and the canonical site (Site 2) are sequentially involved in polyubiquitin chain formation.
- This detailed mechanistic understanding provides new insights into the ubiquitin-proteasome system and E3 ligase function.
Related Concept Videos
02:58Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
01:57Protein Complexes with Interchangeable Parts
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
01:17The Proteasome Structure
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...